Latest Pradaxa news
Dabigatran May Be Better Than Warfarin After Bleeding Episode
posted December 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Dabigatran is less likely than warfarin to cause recurrent bleeding in atrial fibrillation patients who have experienced a major bleeding event, according to a study published online Dec. 1 in Stroke.
Higher Bleeding Risk Seen With Rivaroxaban Versus Dabigatran
posted October 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Rivaroxaban may pose a slightly greater risk of serious bleeding than dabigatran in patients with atrial fibrillation, according to a study published online Oct. 3 in JAMA Internal Medicine.
Editor's Recommendations
Cannabis Legalization Linked to More Heart-Related Hospitalizations 
Retinal Imaging Can ID Atrial Fibrillation Years Before Diagnosis 
NOACs Linked to Slower Cognitive Decline in Patients With A-Fib, Alzheimer Disease 
Central Adiposity Reclassifies Cardiovascular Risk Across BMI Spectrum 
Elevated C-Reactive Protein Linked to Increased Risk for Incident Heart Failure, All-Cause Mortality 
UACR, UPCR Provide Indistinguishable Prognostic Information in CKD 
Use of SAMA, SABA Linked to Cardiovascular Events, Mortality in Asthma, COPD 
Smartwatches Significantly Overestimate How Many Calories Are Burned Monthly Specialist Briefings
Stay Connected
